Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

TGTXTGTX
Showing 8 of 28 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in TG THERAPEUTICS INC

Yes. Two Sigma holds 2,468,971 shares of TGTX (TG Therapeutics), worth $135.6M, as of its Q2 2026 13F filing. It increased the position by 926,659 shares (+60.1%) from Q1 2026. Two Sigma has held TGTX since Q1 2022, across 18 quarterly 13F filings. TGTX is 0.1% of Two Sigma's reported 13F portfolio.

Current Value

$135.6M

Current Shares

2.5M

Total Value Change

+$110.8M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+60.1%
$135.6M0.1%$54.94
43
2026-Q1
Increased
1.5M
+45.4%
$51.2M0.0%$33.22
40
2025-Q4
Increased
1.1M
+19.2%
$31.6M0.0%$29.81
34
2025-Q3
Increased
889,870
+45.0%
$32.1M0.0%$36.13
39
2025-Q2
Decreased
613,707
-22.7%
$22.1M0.0%$35.99
0
2025-Q1
Increased
793,639
+30.9%
$31.3M0.1%$39.43
37
2024-Q4
Decreased
606,208
-43.0%
$18.2M0.0%$30.10
0
2024-Q3
Decreased
1.1M
-21.9%
$24.9M0.1%$23.39
0

Other major holders of TGTX: BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used